SCHEMBL16384264

SCHEMBL16384264

Nc1cc2c(cc1O)-c1ccccc1C21c2ccccc2-c2cc(N)c(O)cc21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
KDM4E B2RXH2 2/20 0.46
LMNA P02545 2/20 0.46
MAPT P10636 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
OPRK1 P41145 1/20 0.46
ESR1 P03372 1/20 0.42
ESR2 Q92731 1/20 0.42
PDK2 Q15119 12/20 0.39
ALOX15 P16050 2/20 0.34
HPGD P15428 2/20 0.34
USP2 O75604 1/20 0.34
ALDH1A1 P00352 1/20 0.34
HSP90AA1 P07900 1/20 0.34
GAA P10253 1/20 0.34
ALOX12 P18054 1/20 0.34
HTT P42858 1/20 0.34
HSD17B10 Q99714 1/20 0.34
MCL1 Q07820 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16381561 0.96 MEN1 (0.48) MEN1KMT2AKDM4ELMNAMAPT
SCHEMBL8984777 0.96 MEN1 (0.48) MEN1KMT2AKDM4ELMNAMAPT
SCHEMBL17443129 0.96 MEN1 (0.48) MEN1KMT2AKDM4ELMNAMAPT
SCHEMBL17789210 0.89 ESR1 (0.51) MEN1KMT2AKDM4ELMNAMAPT
SCHEMBL19307998 0.87 ESR1 (0.53) MEN1KMT2AKDM4ELMNAMAPT
SCHEMBL8984804 0.85 MAPT (0.55) MEN1KMT2AKDM4ELMNAMAPT
SCHEMBL18327684 0.85 ESR1 (0.50) MEN1KMT2AKDM4ELMNAMAPT
SCHEMBL4271007 0.85 ESR1 (0.50) MEN1KMT2AKDM4ELMNAMAPT
SCHEMBL20942083 0.85 ESR1 (0.50) MEN1KMT2AKDM4ELMNAMAPT
SCHEMBL28227922 0.79 PDK2 (0.39) MEN1KMT2AKDM4ELMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3016956-B1 DIANHYDRIDES, POLYIMIDES, METHODS OF MAKING EACH, AND METHODS OF USE UNIV KING ABDULLAH SCI & TECH (SA) 2019-02-20 EP disclosed
US-9840514-B2 Dianhydrides, polyimides, methods of making each, and methods of use KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY (SA) 2017-12-12 US disclosed
US-20160152630-A1 DIANHYDRIDES, POLYIMIDES, METHODS OF MAKING EACH, AND METHODS OF USE KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY (SA) 2016-06-02 US disclosed
WO-2015001422-A2 DIANHYDRIDES, POLYIMIDES, METHODS OF MAKING EACH, AND METHODS OF USE KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY (SA) 2015-01-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160152630-A1 DIANHYDRIDES, POLYIMIDES, METHODS OF MAKING EACH, AND METHODS OF USE ALKBH3, ALK, DDC MEN1 1957/4885KMT2A 595/4885KDM4E 391/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.